Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Clinical trial NCT00077922 · COMPLETED

Trial details

NCT number: NCT00077922
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Lymphocytic Chronic

Start date: 2004-02-29
Primary completion: 2011-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.